Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

186.96
Delayed Data
As of May 27
 -3.29 / -1.73%
Today’s Change
147.60
Today|||52-Week Range
270.63
-8.80%
Year-to-Date
Shire Expects to Wrap Up Baxalta Buy on June 3
May 27 / TheStreet.com - Paid Partner Content
CF Industries Pulls $8B Takeover of OCI Assets
May 23 / TheStreet.com - Paid Partner Content
Baxalta Reports Positive Phase I Study Data on BAX 930
May 26 / Zacks.com - Paid Partner Content
British CEOs should take a 50% pay cut
May 20 / CNNMoney.com
3 Stocks Underperforming Today In The Drugs Industry
May 26 / TheStreet.com - Paid Partner Content
5 Foreign Stocks Worth Investing Post-Q1 Earnings
May 17 / Zacks.com - Paid Partner Content
5 Health Care Stocks Whose Charts Tell You to Wait to Buy
May 26 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close190.25
Today’s open189.44
Day’s range185.04 - 190.36
Volume7,696,344
Average volume (3 months)2,525,314
Market cap$37.1B
Dividend yield0.73%
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-61.89%
Earnings growth (this year)+9.57%
Earnings growth (next 5 years)+12.85%
Revenue growth (last year)+6.79%
P/E ratio27.7
Price/Sales6.33
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+2.25+1.52%
ZTSZoetis Inc-0.15-0.32%
VRTXVertex Pharmaceutica...+1.19+1.33%
MYLMylan NV+0.20+0.47%
Data as of 4:04pm ET, 05/27/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$3.09
Annual revenue (last year)$6.4B
Annual profit (last year)$1.3B
Net profit margin20.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs